Acasti Pharma Announces 1-for-6 Reverse Stock Split
- Friday, July 7, 2023, 7:01
- Finance
- Add a comment
LAVAL, QB, July 7, 2023 /PRNewswire/ — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage…
About the Author
adminasapcorp has written 39725 stories on this site.